EUVIMEDEUVIMED entdecken
Open Access

Analysis : Intravascular Devices with a Higher Risk of Polymer Emboli: The Need for Particulate Generation Testing

Amitabh Madhukumar Chopra, Amy Rapkiewicz, Ramesh Daggubati, Adrian Sequeira, Yin C Hu, Deepak L Bhatt, Samin K Sharma, Juan Pablo Cruz, Abraham R Tzafriri, Elazer R Edelman

Biomedical Instrumentation & Technology · 2020-01 · 54 (1) · 37-43

DOI: 10.2345/0899-8205-54.1.37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Instrumentation & Technology, 2020-01. Verfasst von Amitabh Madhukumar Chopra und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Embolism. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydrophilic polymer coatings on intravascular devices lower friction between the device and vasculature, thereby reducing trauma during interventional procedures. Polymer coating embolism-the detachment and downstream embolism of polymer particles-has been reported as an iatrogenic complication of coated interventional devices affecting the vasculature and various organs. The Food and Drug Administration (FDA) acknowledges this complication and continues to work with stakeholders to close gaps in performance testing and standards related to polymer coating integrity. Recent innovations within interventional technologies have led to development of new hydrophilic-coated devices with expanded indications for use. The 2018 FDA draft guidance for intravascular guidewires expands the application of particulate generation testing to most devices and recommends labeling changes to increase industry awareness. This article highlights current procedural trends where the phenomenon of polymer coating embolism may be more prevalent. It describes the mechanisms of polymer separation, reported clinical sequelae, and risk factors for relevant indications. These procedural trends and associated risk factors articulate the need for particulate testing and support the FDA's draft guidance recommendations for performance testing of applied coatings. If standardized, particulate assessments may allow characterization and comparisons of coating integrity among devices from various manufacturers, and are an important foundation for setting particulate limits. As hydrophilic coatings enable endovascular treatment for a range of patient populations, setting particulate limits or finding alternative solutions without compromise to device function may be essential. Particulate testing is relevant to physicians, regulators, and manufacturers for the purposes of product development and quality improvement of interventional devices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EmbolismCoated Materials, BiocompatibleHumansHydrophobic and Hydrophilic InteractionsPolymersUnited StatesUnited States Food and Drug Administration

Substanzen

Coated Materials, BiocompatiblePolymers

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Chopra, A. M., Rapkiewicz, A., Daggubati, R., Sequeira, A., Hu, Y. C., Bhatt, D. L., Sharma, S. K., Cruz, J. P., Tzafriri, A. R., & Edelman, E. R. (2020). Analysis : Intravascular Devices with a Higher Risk of Polymer Emboli: The Need for Particulate Generation Testing. Biomedical Instrumentation & Technology, 54(1), 37-43. https://doi.org/10.2345/0899-8205-54.1.37

Vancouver

Chopra AM, Rapkiewicz A, Daggubati R, Sequeira A, Hu YC, Bhatt DL, et al. Analysis : Intravascular Devices with a Higher Risk of Polymer Emboli: The Need for Particulate Generation Testing. Biomedical Instrumentation & Technology. 2020;54(1):37-43. doi:10.2345/0899-8205-54.1.37

BibTeX
@article{Chopra2020,
  author = {Chopra, Amitabh Madhukumar and Rapkiewicz, Amy and Daggubati, Ramesh and Sequeira, Adrian and Hu, Yin C and Bhatt, Deepak L and Sharma, Samin K and Cruz, Juan Pablo and Tzafriri, Abraham R and Edelman, Elazer R},
  title = {Analysis : Intravascular Devices with a Higher Risk of Polymer Emboli: The Need for Particulate Generation Testing},
  journal = {Biomedical Instrumentation & Technology},
  year = {2020},
  volume = {54},
  number = {1},
  pages = {37--43},
  doi = {10.2345/0899-8205-54.1.37}
}
Kostenlos starten →